rs146464426

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The ENST00000528731.1(KCNJ11):​c.-17+514C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000675 in 349,518 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

KCNJ11
ENST00000528731.1 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -2.11

Publications

1 publications found
Variant links:
Genes affected
KCNJ11 (HGNC:6257): (potassium inwardly rectifying channel subfamily J member 11) Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009]
KCNJ11 Gene-Disease associations (from GenCC):
  • diabetes mellitus, transient neonatal, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hyperinsulinemic hypoglycemia, familial, 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • diabetes mellitus, permanent neonatal 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young type 13
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal dominant hyperinsulinism due to Kir6.2 deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • DEND syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate DEND syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • permanent neonatal diabetes mellitus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • transient neonatal diabetes mellitus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive hyperinsulinism due to Kir6.2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-17388660-G-A is Benign according to our data. Variant chr11-17388660-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 435555.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00139 (211/151622) while in subpopulation AFR AF = 0.00461 (191/41404). AF 95% confidence interval is 0.00408. There are 1 homozygotes in GnomAd4. There are 78 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNJ11NM_001166290.2 linkc.-17+514C>T intron_variant Intron 1 of 1 NP_001159762.1 Q14654-2A0A804HHV7
KCNJ11NM_001377296.1 linkc.-76+181C>T intron_variant Intron 1 of 2 NP_001364225.1
KCNJ11NM_001377297.1 linkc.-17+181C>T intron_variant Intron 1 of 1 NP_001364226.1
KCNJ11NM_000525.4 linkc.-569C>T upstream_gene_variant ENST00000339994.5 NP_000516.3 Q14654-1B2RC52

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNJ11ENST00000339994.5 linkc.-569C>T upstream_gene_variant 6 NM_000525.4 ENSP00000345708.4 Q14654-1

Frequencies

GnomAD3 genomes
AF:
0.00139
AC:
210
AN:
151510
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00460
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00112
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000961
GnomAD4 exome
AF:
0.000126
AC:
25
AN:
197896
Hom.:
0
Cov.:
0
AF XY:
0.000110
AC XY:
12
AN XY:
108788
show subpopulations
African (AFR)
AF:
0.00469
AC:
21
AN:
4474
American (AMR)
AF:
0.00
AC:
0
AN:
12110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3908
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5590
South Asian (SAS)
AF:
0.00
AC:
0
AN:
41744
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22318
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2090
European-Non Finnish (NFE)
AF:
0.0000103
AC:
1
AN:
96730
Other (OTH)
AF:
0.000336
AC:
3
AN:
8932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00139
AC:
211
AN:
151622
Hom.:
1
Cov.:
32
AF XY:
0.00105
AC XY:
78
AN XY:
74044
show subpopulations
African (AFR)
AF:
0.00461
AC:
191
AN:
41404
American (AMR)
AF:
0.00111
AC:
17
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10380
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67866
Other (OTH)
AF:
0.000951
AC:
2
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00133
Hom.:
1
Bravo
AF:
0.00173
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Maturity onset diabetes mellitus in young Uncertain:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of this particular variant (rs146464426) in MODY yet. -

not specified Benign:1
Dec 09, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KCNJ11-related disorder Benign:1
May 27, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.46
DANN
Benign
0.61
PhyloP100
-2.1
PromoterAI
0.024
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146464426; hg19: chr11-17410207; API